Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The future of best practice.

J J Kastelein1

  • 1Academic Medical Centre, University of Amsterdam, Department of Vascular Medicine, The Netherlands.

Atherosclerosis
|June 26, 1999
PubMed
Summary
This summary is machine-generated.

Lowering cholesterol significantly reduces cardiovascular disease risk for most patients. While achieving lower low-density lipoprotein cholesterol levels offers greater benefits, the advantages of extremely low levels remain uncertain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia : A Comparison with Gemfibrozil.

Clinical drug investigation·2016
Same author

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.

Clinical drug investigation·2013
Same author

ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans.

Journal of thrombosis and haemostasis : JTH·2008
Same author

Systemic inflammation as a risk factor for atherothrombosis.

Rheumatology (Oxford, England)·2007
Same author

[Genetic screening of patients with familial hypercholesterolemia and insurability for life insurance policies and disability cover policies].

Nederlands tijdschrift voor geneeskunde·2004
Same author

The outcome of angiography in patients with Raynaud's phenomenon: an unexpected role for atherosclerosis and hypercholesterolemia.

Clinical and experimental rheumatology·2003

Area of Science:

  • Cardiology
  • Epidemiology
  • Pharmacology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality despite treatment advances.
  • Cholesterol lowering is a cornerstone in managing coronary artery disease (CAD).
  • Drug therapy is often necessary for patients to reach target lipid levels.

Purpose of the Study:

  • To review the established importance of cholesterol lowering in reducing cardiovascular risk.
  • To examine the impact of achieving reduced low-density lipoprotein cholesterol levels.
  • To assess the current evidence regarding the benefits of lowering cholesterol to very low levels.

Main Methods:

  • Analysis of epidemiological and clinical studies.
  • Review of subgroup data from landmark statin trials.

Related Experiment Videos

  • Evaluation of recent evidence on cholesterol reduction and cardiovascular event risk.

    • Main Results:

    • Cholesterol lowering is proven to reduce the risk of coronary artery disease (CAD) across diverse patient groups.
    • Greater reductions in low-density lipoprotein cholesterol are associated with more significant decreases in cardiovascular event risk.
    • Current data do not definitively establish the benefits of lowering cholesterol to very low levels.

    Conclusions:

    • Cholesterol management remains critical in preventing cardiovascular events.
    • Further research is needed to determine optimal low-density lipoprotein cholesterol targets.
    • Personalized treatment strategies are essential for effective CAD management.